Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors

2021 ◽  
Vol 22 (5) ◽  
Author(s):  
Zonghua Tian ◽  
Yaping Mai ◽  
Tingting Meng ◽  
Shijie Ma ◽  
Guojing Gou ◽  
...  
2021 ◽  
Vol 35 (3) ◽  
pp. 2033-2047
Author(s):  
Xiangyu Liu ◽  
Liehui Zhang ◽  
Yulong Zhao ◽  
Xiao He ◽  
Jianfa Wu ◽  
...  

Pharmaceutics ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 167
Author(s):  
Yu Wang ◽  
Xu Bai ◽  
Bo Hu ◽  
Maochen Xing ◽  
Qi Cao ◽  
...  

Detailed knowledge of the intestinal transport of polymannuronic acid (PM) and polyguluronic acid (PG) is critical for understanding their biological activities. To investigate the transport in the gastrointestinal tract, PM and PG were chemically modified with tyramine and conjugated with fluorescein isothiocyanate (FITC) to synthesize FITC-PM (F-PM) and FITC-PG (F-PG) successfully. The transport mechanisms of F-PM and F-PG across the intestinal epithelial cell monolayers (Caco-2 cell monolayers) were then investigated. The results demonstrated that the transport of F-PM and F-PG into epithelial cells was time- and energy-dependent, which was mediated by the macropinocytosis pathway and the clathrin- and caveolae (or lipid raft)-mediated endocytic pathway. The transport process of F-PM and F-PG in Caco-2 cells depended on the acidification of endosomes and involved lysosomes. Tubulin mediated the transport of F-PM, but not of F-PG. Moreover, the absorption enhancer chitosan (CS) promoted the transport of F-PM and F-PG, increasing the apparent permeability coefficient (Papp) by 1.9-fold and 2.6-fold, respectively, by reversibly opening the tight junction (TJ). In summary, this study provided a comprehensive understanding of the transport of PM and PG in the small intestinal epithelial cells, which will provide a theoretical basis for the development of PM and PG with good intestinal absorption.


2020 ◽  
Vol 13 (4) ◽  
pp. 1660
Author(s):  
Mohammed Abdul Aziz Shahid ◽  
Y Shravan Kumar ◽  
Syed Umar Farooq ◽  
Md. Shamim Qureshi

2018 ◽  
Vol Volume 13 ◽  
pp. 3781-3793 ◽  
Author(s):  
Wei Xiong ◽  
Wei Sang ◽  
Ke Gang Linghu ◽  
Zhang Feng Zhong ◽  
Wai San Cheang ◽  
...  

OCL ◽  
2022 ◽  
Vol 29 ◽  
pp. 1
Author(s):  
Camille Dumont

Therapeutic peptides can treat a wide variety of diseases with selective and potent action. Their oral bioavailability is strongly limited by an important proteolytic activity in the intestinal lumen and poor permeation across the intestinal border. We have evaluated the capacity of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) to overcome both oral bioavailability limiting aspects, using leuprolide (LEU) as model peptide. Lipidization of LEU by formation of a hydrophobic ion pair (HIP) with sodium docusate enables a significant increase of peptide encapsulation efficiency in both SLN and NLC. The nanocarriers, obtained by high-pressure homogenization, measured 120 nm and were platelet shaped. Regarding the protective effect towards proteolytic degradation, only NLC maintained LEU integrity in presence of trypsin. Intestinal transport, evaluated on Caco-2 (enterocyte-like model) and Caco-2/HT29-MTX (mucin-secreting model) monolayers, showed nanocarriers internalization by enterocytes but no improvement of LEU permeability. Indeed, the combination of nanoparticles platelet-shape with the poor stability of the HIP in the transport medium induces a high burst release of the peptide, limiting nanoparticles capacity to transport LEU across the intestinal border. Stability of peptide lipidization needs to be improved to withstand biorelevant medium to benefit from the advantages of encapsulation in solid lipid nanocarriers and consequently improve their oral bioavailability.


Author(s):  
Bhargavi Latha Athukuri ◽  
Prasad Neerati

Abstract Background: Cytochrome P450-2D6 (CYP2D6), a member of the CYP450 mixed function oxidase system, is an important CYP isoform with regard to herbal-drug interactions and is responsible for the metabolism of nearly 25% of drugs. Until now, studies on the effects of various phytochemicals on CYP2D6 activity Methods: The intestinal transport of metoprolol was assessed by conducting an Results: After pretreatment with gallic acid and ellagic acid, no significant change in effective permeability of metoprolol was observed at the ileum part of rat intestine. A significant improvement in the peak plasma concentration (C Conclusions: Gallic acid and ellagic acid significantly enhanced the oral bioavailability of metoprolol by inhibiting CYP2D6-mediated metabolism in the rat liver. Hence, adverse herbal-drug interactions may result with concomitant ingestion of gallic acid and ellagic acid supplements and drugs that are CYP2D6 substrates. The clinical assessment of these interactions should be further investigated in human volunteers.


RSC Advances ◽  
2015 ◽  
Vol 5 (117) ◽  
pp. 96437-96447 ◽  
Author(s):  
Guihua Fang ◽  
Bo Tang ◽  
Yanhui Chao ◽  
Yu Zhang ◽  
Hui Xu ◽  
...  

The objective of the current study was to explore the potential of nanostructured lipid carriers (NLC) for oral delivery of docetaxel (DTX) and investigate the absorption mechanismin vivo.


1976 ◽  
Vol 54 (1) ◽  
pp. 109-111 ◽  
Author(s):  
Joseph Lerner ◽  
Peter H. Burrill ◽  
Peggy A. Sattelmeyer ◽  
Caryle F. Janicki

Sign in / Sign up

Export Citation Format

Share Document